Clinical trials of a new antitumor polypeptide: neocarzinostatin (NCS).
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use* / Q000633:toxicity; D002277:Carcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D010455:Peptides / Q000627:therapeutic use* / Q000633:toxicity; D013302:Streptomyces / Q000302:isolation & purification
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D010455:Peptides; D003520:Cyclophosphamide; D005472:Fluorouracil